DGAP-Ad hoc: aap Implantate AG english
aap gains CE approval for knee endoprosthetics sector
Ad-hoc-announcement processed and transmitted by DGAP.
The issuer is solely responsible for the content of this announcement.
--------------------------------------------------
aap gains CE approval for knee endoprosthetics sector
Metal and biological implant specialist aap Implantate AG has
received European certification for an innovative knee
endoprosthesis and, accordingly, for the knee endoprosthetics
sector. The new knee endoprosthesis was taken to market
maturity by aap as part of a development contract for Munich-
based HJS Gelenk-System GmbH. In securing CE approval, aap has
successfully completed a substantial part of the development
contract.
The HJS implant makes almost natural movements possible by
means of a surface geometry that has been patented worldwide.
The interdisciplinary development team expects implant
patients to be able to be able to move their knees after a
relatively short time without pain once more and without major
restrictions.
Data Monitor estimates the current total European market
volume for knee endoprostheses to amount to roughly US $ 450
million. In combining the competence areas of shoulder, hip
and knee endoprosthetics along with its already established
cement and cement technology products, aap has succeeded in
taking a decisive step toward becoming a single-point
provider.
end of ad-hoc-announcement (c)DGAP 13.05.2002
--------------------------------------------------
WKN: 506660; ISIN: DE0005066609; Index:
Listed: Neuer Markt Frankfurt; Freiverkehr in Berlin, Bremen, Düsseldorf,
Hamburg, Hannover, München und Stuttgart
130835 Mai 02
